• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性痒疹的发病机制——探索“超级瘙痒”

The pathogenesis of Prurigo nodularis--'Super-Itch' in exploration.

作者信息

Zeidler C, Ständer S

机构信息

Department of Dermatology, Center for Chronic Pruritus, University Hospital of Münster, Germany.

出版信息

Eur J Pain. 2016 Jan;20(1):37-40. doi: 10.1002/ejp.767. Epub 2015 Sep 28.

DOI:10.1002/ejp.767
PMID:26416433
Abstract

Prurigo nodularis (PN) is characterized by multiple hyperkeratotic nodules, papules and the presence of intensive pruritus. This leads to an impaired quality of life and high burden due not only to the severe itch but also the chronic, skin lesions and lack of treatment options. The pathogenesis of PN is not completely clarified. Previous studies have demonstrated just how important the interaction between cutaneous nerve fibres and immune cells is. Besides a reduced intraepidermal nerve fibre density, there are increased dermal levels of neuropeptides such as substance P, calcitonin gene-related peptide and nerve growth factor, as well as a predominant presence of eosinophils and mast cells. An interaction of these factors results in a complex relationship which will be discussed in this article.

摘要

结节性痒疹(PN)的特征是有多个角化过度的结节、丘疹,并伴有剧烈瘙痒。这不仅会导致生活质量受损,还会带来沉重负担,这不仅是因为严重瘙痒,还因为慢性皮肤病变以及缺乏治疗选择。PN的发病机制尚未完全阐明。先前的研究已经证明了皮肤神经纤维与免疫细胞之间的相互作用有多重要。除了表皮内神经纤维密度降低外,皮肤中神经肽如P物质、降钙素基因相关肽和神经生长因子的水平也有所升高,同时嗜酸性粒细胞和肥大细胞大量存在。这些因素之间的相互作用导致了一种复杂的关系,本文将对此进行讨论。

相似文献

1
The pathogenesis of Prurigo nodularis--'Super-Itch' in exploration.结节性痒疹的发病机制——探索“超级瘙痒”
Eur J Pain. 2016 Jan;20(1):37-40. doi: 10.1002/ejp.767. Epub 2015 Sep 28.
2
Prurigo nodularis: new insights into pathogenesis and novel therapeutics.结节性痒疹:发病机制的新见解和新疗法。
Br J Dermatol. 2024 May 17;190(6):798-810. doi: 10.1093/bjd/ljae052.
3
Prurigo Nodularis and Its Management.结节性痒疹及其治疗
Dermatol Clin. 2018 Jul;36(3):189-197. doi: 10.1016/j.det.2018.02.003. Epub 2018 Mar 20.
4
Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.结节性痒疹:发病机制与潜在治疗靶点。
Int J Mol Sci. 2024 May 9;25(10):5164. doi: 10.3390/ijms25105164.
5
Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy.结节性痒疹皮损和非皮损皮肤表皮内神经纤维密度降低,可能是亚临床皮肤神经病变的潜在征象。
Br J Dermatol. 2011 Jul;165(1):85-91. doi: 10.1111/j.1365-2133.2011.10306.x.
6
Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.结节性痒疹的瘙痒强度与皮肤白介素-31、成纤维细胞生长因子 22、白细胞介素-31 受体α和白细胞介素-31 受体β密切相关。
Exp Dermatol. 2021 Jun;30(6):804-810. doi: 10.1111/exd.14279. Epub 2021 Feb 1.
7
Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin -- an exploration of the cause of neurohyperplasia.结节性痒疹皮肤中神经生长因子和酪氨酸激酶A样免疫反应性增加——神经增生原因的探索
Arch Dermatol Res. 2002 Feb;293(12):614-9. doi: 10.1007/s00403-001-0285-8. Epub 2002 Feb 5.
8
Prurigo nodularis: a review.结节性痒疹:综述
Australas J Dermatol. 2005 Nov;46(4):211-18; quiz 219-20. doi: 10.1111/j.1440-0960.2005.00187.x.
9
Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.结节性痒疹:一种由持续性瘙痒引起的良性皮肤病。
Acta Dermatovenerol Croat. 2008;16(1):38-44.
10
Prurigo nodularis: Pathogenesis and management.结节性痒疹:发病机制与治疗。
J Am Acad Dermatol. 2020 Dec;83(6):1567-1575. doi: 10.1016/j.jaad.2020.04.182. Epub 2020 May 24.

引用本文的文献

1
A Fleshy Mystery: Prurigo Nodularis.一个肉质谜团:结节性痒疹。
Cureus. 2024 Jul 22;16(7):e65125. doi: 10.7759/cureus.65125. eCollection 2024 Jul.
2
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks.度普利尤单抗治疗结节性痒疹:长达84周的真实疗效
J Clin Med. 2024 Feb 2;13(3):878. doi: 10.3390/jcm13030878.
3
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments.慢性瘙痒症,包括结节性瘙痒症:新的见解和治疗方法。
Am J Clin Dermatol. 2024 Jan;25(1):15-33. doi: 10.1007/s40257-023-00818-z. Epub 2023 Sep 17.
4
Prurigo Nodularis onset during secukinumab treatment of psoriasis: a case report.司库奇尤单抗治疗银屑病期间发生结节性痒疹:一例报告
Allergy Asthma Clin Immunol. 2023 Jul 5;19(1):59. doi: 10.1186/s13223-023-00811-5.
5
The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.睡眠障碍数字评定量表:结节性痒疹的内容效度、心理测量学验证及有意义的患者内变化
Dermatol Ther (Heidelb). 2023 Jul;13(7):1587-1602. doi: 10.1007/s13555-023-00962-8. Epub 2023 Jun 17.
6
A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis.一项真实世界观察性研究:度普利尤单抗治疗结节性痒疹成人患者的疗效。
An Bras Dermatol. 2023 Jul-Aug;98(4):440-448. doi: 10.1016/j.abd.2022.09.008. Epub 2023 Mar 23.
7
Abnormal keratin expression pattern in prurigo nodularis epidermis.结节性痒疹表皮中角蛋白表达模式异常。
Skin Health Dis. 2021 Dec 1;2(1):e75. doi: 10.1002/ski2.75. eCollection 2022 Mar.
8
Immunotargets and Therapy for Prurigo Nodularis.结节性痒疹的免疫靶点与治疗
Immunotargets Ther. 2022 Apr 26;11:11-21. doi: 10.2147/ITT.S316602. eCollection 2022.
9
Controversies in Allergy: The Potential Role of Biologics as First-Line Therapy in Eosinophilic Disorders.过敏症争议:生物制剂在嗜酸性疾病中作为一线治疗的潜在作用。
J Allergy Clin Immunol Pract. 2022 May;10(5):1169-1176. doi: 10.1016/j.jaip.2022.01.043. Epub 2022 Feb 12.
10
Epidemiology of prurigo nodularis in England: a retrospective database analysis.结节性痒疹在英格兰的流行病学:一项回顾性数据库分析。
Br J Dermatol. 2022 Aug;187(2):188-195. doi: 10.1111/bjd.21032. Epub 2022 May 9.